The 9th International Congress on Autoimmunity, which included 3,000 doctors and scientists from around the world, commenced in 2014 to discuss one of the most intriguing and important items in the field of autoimmunity: the discovery of a new post-vaccine disorder associated with vaccine aluminum adjuvants called “Autoimmunity/Inflammatory Syndrome Induced by Adjuvants,” also known as ASIA.
Scientists and organizations like the Children’s Medical Safety Research Institute have long explored autoimmunity and the relationship between aluminum adjuvants in vaccines and adverse autoimmune responses. Aluminum is a known neurotoxin to all organisms, and a breadth of scientific research has demonstrated that aluminum plays a significant role in the development of dementia, autism, and Parkinson’s disease. Aluminum exposure has also been linked to cancer and Alzheimer’s disease, among other adverse health conditions.
ASIA is therefore only the latest autoimmune syndrome in a long list of disorders associated with aluminum adjuvants.
ASIA was first discovered in 2011 by Yehuda Shoenfeld, who characterizes the disorder as encompassing a wide range of symptoms, including weakness, anxiety, rashes, fatigue, sleep disorders, and arthritis, just to name a few. The disorder also refers to any environmental factor demonstrated to trigger autoimmune conditions. This means that aluminum adjuvants are just one of the many environmental factors that can be associated with ASIA. Squalene, a chemical component of vaccines used on Gulf War military members is also linked to autoimmune disorders that fall under the ASIA criteria. ASIA symptoms can manifest within week or years of an aluminum-adjuvant containing vaccine injection.
At the 9th International Autoimmunity Congress, the ASIA Syndrome was the subject of several presentations, including one by Dr. Carlo Perricone. He was among four presenters voted by his peers to present in a final Plenary Session. Interest in Dr. Perricone’s talk and the ASIA Syndrome highlighted the concern among scientists that autoimmune diseases are rapidly increasing, there are few effective treatments, diagnosis has become more difficult due to diverse symptoms, and there is a great need for more research to understand instigators and treatment options to help a rising tide of sick patients. His talk based on his research, “Autoimmune/inflammatory syndrome induced by adjuvants (ASIA) 2013: Unveiling the pathogenic, clinical and diagnostic aspects, underscored the need to understand how vaccine adjuvants are contributing to such serious adverse events such as narcolepsy that was linked to a new adjuvant in some flu vaccines.
The International ASIA Registry
The 9th International Congress on Autoimmunity announced that an official international ASIA registry would be established, and this registry officially opened in January of 2015. The registry is currently being used as a tool to analyze the nature and prevalence of autoimmune diseases throughout the world; with this data, researchers hope to learn more about the specific causes of autoimmunity. Currently, approximately 70% of registered cases followed administration of the Hepatitis B vaccination.
Animal studies have also demonstrated similar adverse autoimmune conditions upon overexposure to aluminum, such as general weakness and muscular atrophy in sheep. Research conducted by leading adjuvant researcher Christopher Shaw found that mice injected with aluminum at levels corresponding to what’s found in vaccines displayed social interaction deficits and elevated anxiety levels.
Find more information about the ASIA Registry and learn how to submit a case study here.